CAS 1030825-28-5

OP-1118

Produit contrôlé

CAS : 1030825-28-5

Applications OP-1118 is a major metabolite of Fidaxomicin (F335400).
References Babakhani, F., et al.: J. Med. Microbiol., 60, 1213 (2011); Allen, C., et al.: Antimicrob. Agents Chemother., 57, 664 (2013)

Formule : C₄₈H₆₈Cl₂O₁₇

Couleur et forme : Neat

Masse moléculaire : 987.95

Ref: TR-O662000

OP-1118

CAS : 1030825-28-5

OP-1118 is a small molecule that inhibits the activity of NF-κB, which is a major regulator of inflammatory responses. It has been shown to have an inhibitory effect on intestinal inflammation and infectious diseases. OP-1118 also has bactericidal properties and can be used in conjunction with antibiotics to treat bacterial infections. This drug is currently undergoing clinical development as a potential treatment for inflammatory bowel disease. Animal studies have shown that OP-1118 has little effect on the gut flora, which may be due to its low plasma concentrations.

Formule : C₄₈H₆₈Cl₂O₁₇

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 987.95 g/mol

Ref: 3D-FO71470

Fidaxomicin Metabolite OP-1118

CAS : 1030825-28-5

Formule : C₄₈H₆₈Cl₂O₁₇

Masse moléculaire : 987.96

Ref: ST-EA-CP-F90002